Odulimomab is a mouse monoclonal antibody directed against LFA-1. Odulimomab is used for the prevention of transplant rejection and for the treatment of various immunological diseases.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.